Related references
Note: Only part of the references are listed.Cannabidiol as potential treatment in refractory pediatric epilepsy
Maria Chiara Paolino et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Cannabidiol as potential treatment in refractory pediatric epilepsy
Maria Chiara Paolino et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
International recommendation for a comprehensive neuropathologic workup of epilepsy surgery brain tissue: A consensus Task Force report from the ILAE Commission on Diagnostic Methods
Ingmar Bluemcke et al.
EPILEPSIA (2016)
Edible Cannabis Products: It Is Time for FDA Oversight
David M. Benjamin et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Cannabis and Neuropsychiatry, 1: Benefits and Risks
Chittaranjan Andrade
JOURNAL OF CLINICAL PSYCHIATRY (2016)
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
Orrin Devinsky et al.
LANCET NEUROLOGY (2016)
Cannabidiol and epilepsy: Rationale and therapeutic potential
Antonio Leo et al.
PHARMACOLOGICAL RESEARCH (2016)
CBD-enriched medical cannabis for intractable pediatric epilepsy The current Israeli experience
Michal Tzadok et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2016)
Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome
Marta Rubio et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2016)
Cannabidiol and Sodium Nitroprusside: Two Novel Neuromodulatory Pharmacological Interventions to Treat and Prevent Psychosis
Jose Alexandre Crippa et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2015)
Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
Alexandra L. Geffrey et al.
EPILEPSIA (2015)
Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy
Craig A. Press et al.
EPILEPSY & BEHAVIOR (2015)
Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products
Ryan Vandrey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Cannabinoids and Epilepsy
Evan C. Rosenberg et al.
NEUROTHERAPEUTICS (2015)
Cannabinoids in the Treatment of Epilepsy
Daniel Friedman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Phytocannabinoids and epilepsy
R. G. dos Santos et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2015)
Cannabis and other illicit drug use in epilepsy patients
M. Hamerle et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
Adverse Health Effects of Marijuana Use
Nora D. Volkow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy
Brenda E. Porter et al.
EPILEPSY & BEHAVIOR (2013)
Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers
R. Martin-Santos et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Internet Highs-Seizures After Consumption of Synthetic Cannabinoids Purchased Online
Babak Tofighi et al.
JOURNAL OF ADDICTION MEDICINE (2012)
Patterns of treatment response in newly diagnosed epilepsy
M. J. Brodie et al.
NEUROLOGY (2012)
Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis
Susanne A. Wolf et al.
CELL COMMUNICATION AND SIGNALING (2010)
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
Antonio Waldo Zuardi
REVISTA BRASILEIRA DE PSIQUIATRIA (2008)
Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
Alline Cristina Campos et al.
PSYCHOPHARMACOLOGY (2008)
Neurogenesis and schizophrenia: dividing neurons in a divided mind?
Andreas Reif et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2007)
Share Paper
